TABLE 2.
MCT-NEs (n = 10) | MCT-Es (n = 10) | |||||
---|---|---|---|---|---|---|
10 g | 20 g | 30 g | 10 g | 20 g | 30 g | |
Abdominal discomfort | 1 (M) | 3 (S) | 4 (M) | 2 (M) | 2 (L) | 4 (S) |
Decreased appetite | — | — | 1 (L) | 1 (L) | 1 (L) | 1 (M) |
Gastric reflux | — | — | 1 (L) | — | 1 (L) | — |
Nausea | — | — | — | — | 2 (L) | 1 (L) |
Diarrhea | 1 (M) | 2 (M) | 5 (S) | — | — | — |
Headache | — | 1 (M) | — | — | — | — |
Participants reporting side effects, n | 1 | 4 | 5 | 2 | 4 | 5 |
Total number of side effects reported | 2 | 6 | 11 | 3 | 6 | 6 |
Severity scale (0–10): L, 0–3; M, 4–7; S, 8–10. The severity level was based on the highest score reported. L, light; M, moderate; MCT-E, emulsified medium-chain TG; MCT-NE, nonemulsified medium-chain TG; S, severe.